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Abstract 
Melatonin is a possible protective agent in postburn gut pathophysiological dynamics. We 
investigated the role of endogenously-produced versus exogenously-administered melatonin 
in a major thermal injury rat model with well-characterized gut inflammatory complications. 
Our rationale is that understanding in vivo melatonin mechanisms in control and inflamed 
tissues will improve our understanding of its potential as a safe anti-inflammatory/antioxidant 
therapeutic alternative. Towards this end, we tested the hypothesis that the gut is both a 
source and a target for melatonin and that mesenteric melatonin plays an anti-inflammatory 
role following major thermal injury in rats with 3
rd degree hot water scald over 30% TBSA. 
Our methods for assessing the gut as a source of melatonin included plasma melatonin ELISA 
measurements in systemic and mesenteric circulation as well as rtPCR measurement of je-
junum and terminal ileum expression of the melatonin synthesizing enzymes arylalkylamine 
N-acetyltransferase (AA-NAT) and 5-hydroxyindole-O-methyltransferase (HIOMT) in sham 
versus day-3 postburn rats. Our melatonin ELISA results revealed that mesenteric circulation 
has much higher melatonin than systemic circulation and that both mesenteric and systemic 
melatonin levels are increased three days following major thermal injury. Our rtPCR results 
complemented the ELISA data in showing that the melatonin synthesizing enzymes AA-NAT 
and HIOMT are expressed in the ileum and jejunum and that this expression is increased 
three days following major thermal injury. Interestingly, the rtPCR data also revealed negative 
feedback by melatonin as exogenous melatonin supplementation at a dose of 7.43 mg (32 
μmole/kg), but not 1.86 mg/kg (8 μmole/kg) drastically suppressed AA-NAT mRNA expres-
sion. Our methods also included an assessment of the gut as a target for melatonin utilizing 
computerized immunohistochemical measurements to quantify the effects of exogenous 
melatonin supplementation on postburn gut mucosa barrier inflammatory profiles. Here, our 
results revealed that daily postburn intraperitoneal melatonin administration at a dose of 1.86 
mg/kg (8 μmole/kg) significantly suppressed both neutrophil infiltration and tyrosine nitro-
sylation as revealed by Gr-1 and nitrotyrosine immunohistochemistry, respectively. In con-
clusion, our results provide support for high mesenteric melatonin levels and dynamic de novo 
gut melatonin production, both of which increase endogenously in response to major thermal 
injury, but appear to fall short of abrogating the excessive postburn hyper-inflammation. 
Moreover, supplementation by exogenous melatonin significantly suppresses gut inflamma-
tion, thus confirming that melatonin is protective against postburn inflammation.  
Key words: Melatonin, burn, gut barrier, nitrotyrosine, inflammation, sepsis, ELISA, rtPCR, 
HIOMT, AA-NAT, neutrophils, extravasation, ileum, jejunum, mesenteric, immunohistochemistry, 
GR1. Int. J. Biol. Sci. 2010, 6 
 
 
http://www.biolsci.org 
283
1. Introduction 
Intestinal barrier dysfunction plays a major role 
in the pathophysiology of many disorders including 
postburn intestinal sepsis where the gut has been de-
scribed as a “motor” that drives sepsis [1-7]. Central to 
this role is a dynamic and delicate homeostatic bal-
ance that involves a complex web of intricate internal 
mechanisms that span paracrine, endocrine, nervous, 
as well as innate and adaptive immune responses 
alongside external environmental parameters that 
include circadian synchronization, gut microbiota and 
digestion-related agents [1-9]. The complexity of these 
interlinking factors masks the importance of individ-
ual players in the overall, integrated, whole organ-
ism-level responses to major injury. This complexity 
makes it difficult to explain individual clinical varia-
tions often encountered in patient or animal models 
subjected to the same traumatic insult. Indeed, our 
own interest in pursuing sources of such variations 
was triggered by the persistent observation of small 
but remarkable subsets of experimental subjects that 
survived major thermal injury with modest, if any, 
signs of intestinal inflammation, where the trend in 
the majority of their closely-related and identical-
ly-raised, -housed and -treated littermates was to ex-
hibit severe distress. Here, we focus on mesenteric 
melatonin as a possible protective player among the 
myriad of other possible sources of variation in gut 
inflammatory responses [8-12].  
To date, there is mounting evidence for extrapi-
neal, non-circadian, protective roles for gastrointes-
tinal melatonin [13-18]. In spite of being lipophilic, 
melatonin has been shown to be localized at relatively 
high concentrations in various body compartments 
that include bile, ovary, bone and cerebrospinal fluid 
[15-17, 19-23]. Indeed, daytime melatonin has been 
reported at 20 to 30 times higher concentration in bile 
than in the general blood circulation in many mam-
mals, including rats and humans [23]. The persistence 
of such high melatonin levels, at times of low melato-
nin synthesis by pineal synthesizing enzymes arylal-
kylamine N-acetyltransferase (AA-NAT) and 
5-hydroxyindole-O-methyltransferase (HIOMT), 
points to extrapineal melatonin synthesis and/or to 
the presence of melatonin binding proteins that aid in 
compartmentalizing melatonin [15-19,22]. Once ex-
creted, bile melatonin is thought to play a protective 
antioxidant/anti-inflammatory role against gut epi-
thelial damage where it could also be reabsorbed and 
recycled in the bile [13,14,21-30]. Moreover, evidence 
exists for de novo melatonin synthesis and high tissue 
melatonin levels in the gut [13,14]. Taken together, 
these observations suggest the gut as a source for 
melatonin with a persistently high extrapineal me-
senteric melatonin pool, independent of diurnal sys-
temic melatonin fluctuations. Additionally, mounting 
evidence suggests that the gut mucosa barrier tissue is 
a target for melatonin’s protective actions [13-18]. 
Evidence for anti-inflammatory/antioxidant melato-
nin actions has been reported in several tissue targets 
[22-30] and melatonin has been shown to be beneficial 
for burn inflected subjects [31,32].  
These observations point to a great therapeutic 
potential, especially in relation to gut barrier inflam-
matory abnormalities associated with major thermal 
injury and postburn intestinal sepsis pathogenesis 
[1-3]. Here, we begin to closely explore this potential 
by examining melatonin’s postburn gut pathophysi-
ological dynamics. Specifically, we utilize a rodent 
animal model of major thermal injury with 
well-characterized postburn gut barrier abnormalities 
to test the hypothesis that the gut is a source and a 
target for melatonin. Towards this end, we assess gut 
melatonin dynamics by comparing daytime mesen-
teric versus systemic blood melatonin levels, and by 
examining intestinal tissue AA-NAT and HIOMT 
mRNA changes in response to exogenous melatonin 
injection or to major thermal injury. We also investi-
gate the inflammatory/antioxidant effects of melato-
nin by assessing neutrophil infiltration and protein 
nitrosylation in the gut mucosa milieu in the after-
math of major thermal injury, in the presence and 
absence of exogenous melatonin supplementation.   
2. Materials and Methods  
Thermal Injury Protocol.  
Male Harlan Sprague-Dawley rats weighing 
250–300 g (Indianapolis, IN) were used in this inves-
tigation. All animal housing, experimentation and 
treatment were based on previously published pro-
tocols approved by the Chicago State University 
Animal Care and Use Committee (IACUC) and in 
accordance with NIH guidelines [1-3].  All rats (1) 
were acclimatized in the animal facility for at least one 
week before being subjected to any treatment; (2) 
were given free access to water and standard lab rat 
chow ad libitum and kept in a 12:12 light-dark from 
time of arrival till sacrifice; and (3) unless otherwise 
noted, all treatments including major thermal injury 
(TI) were carried out between zeitgeber time (ZT) 6 
and 8, where ZT 0 represents the onset of the light 
period of the L–D cycle at 6 a.m. Major thermal injury 
protocols were previously described and shown to be 
associated with full thickness 3rd degree skin burns Int. J. Biol. Sci. 2010, 6 
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over ~30% of the total body surface associated with 
fairly consistent inflammation-linked immune as well 
as gut barrier abnormalities [1-3]. Accordingly, upon 
verification of deep anest h e s i a  w i t h  s o d i u m  p e n t o -
barbital (40-50 mg/kg intraperitoneal, i.p.), as deter-
mined by absence of any signs of awareness including 
response to hind limb pinch, rats were subjected to the 
following steps in quick succession: (1) the back fur 
was shaved off (~30% TBSA), (2) rats were securely 
placed in an appropriately-sized bottomless plastic 
mold that allows the shaved area of the skin on the 
back to be immersed in water while the rest of the 
body is protected, (3) the back was immersed in a hot 
water bath (95-97 ºC) for 10 seconds, (4) excess hot 
water was immediately wiped off to avoid an addi-
tional injury, and (5) 10 ml of normal saline was in-
jected intraperitoneally for resuscitation. 
Experimental groups and melatonin treatment:  
To assess circulating and mesenteric plasma 
melatonin levels by ELISA, three groups were com-
pared, namely, sham, 3-day-postburn, and sham rats 
sacrificed 2 hours after exogenous melatonin 
(Sham+mel; 2mM, 1 ml/250 g b.wt., i.p.) injection. To 
assess the effect of thermal injury and exogenous me-
latonin on gut AA-NAT and HIOMT mRNA expres-
sion, four groups were compared, namely: sham, 
3-day-postburn, and 3-day-postburn rats sacrificed 2 
hours after exogenous melatonin injection at a dose of 
2 or 8 mM at 1ml/250 g b.wt. i.p. 
To determine the anti-inflammatory/antioxidant 
effects of thermal injury and those of melatonin, four 
matched groups were run in parallel: sham, thermal 
injury (TI), sham plus melatonin (sham+mel), and 
thermal injury plus melatonin (TI+mel). All groups 
received identical anesthesia and treatments as above, 
except that (1) sham and sham+mel were immersed in 
25 ºC instead of 95-97 ºC water (step 3 above) and (2) 
melatonin treatment rats, namely, sham+mel and 
TI+mel, received daily melatonin (Sigma-Aldrich) 
injections (1.86 mg/kg b.wt. dissolved in ~ 1ml saline, 
i.p.) at ZT 6-8 starting just before thermal injury and 
continuing until sacrifice.  
Blood and Tissue Collection:  
All rats were sacrificed under deep anesthesia 
(pentobarbital 40-60 mg/kg) between ZT 6 and 8 on 
day 3 after thermal injury, at which time: (a) mesen-
teric veins draining from the lower bowel into the 
hepatic portal vein were microscopically identified 
and punctured; because this is a terminal procedure, 
we found this approach to be a simple and 
straightforward alternative for sampling mesenteric 
blood without cannulating the mesenteric and/or 
portal veins and the complications/trauma and other 
variables they may introduce [19, 33,34], (b) systemic 
circulating blood was obtained by transcardial punc-
ture, and (c) jejunum and terminal ileum samples 
were immediately dissected. Blood samples were 
collected in heparinized syringes and tubes and im-
mediately preserved on ice and quickly centrifuged to 
obtain plasma which was immediately stored under 
-80 ºC until use. Plasma and terminal ileum as well as 
jejunum samples were snap frozen in liquid nitrogen 
and stored in a -80 ºC deep freezer until use for rtPCR 
methods. Additional terminal ileum and jejunum 
samples were fixed in 4% paraformaldehyde and 
preserved at 4 ºC until being cut for immunohisto-
chemistry into 30 μm frozen sections using a cryostat 
(HM525 Clinical/ Research Cryostat, Richard-Allan 
Scientific HM 550).  
Melatonin ELISA:  
Melatonin levels were compared in mesenteric 
and systemic general blood circulation of sham versus 
experimental day-3 major thermal injury rats. Me-
senteric plasma was obtained from blood pooled in 
the peritoneal cavity upon puncturing the lower me-
senteric microvasculature draining the small and 
large bowel and leading to the hepatic portal vein. 
Systemic plasma was collected from blood drawn 
transcardially through the left ventricle wall. In both 
cases, blood was collected at ~ZT 8 upon terminal 
deep anesthesia with sodium pentobarbital (40-60 
mg/kg intraperitoneal, i.p.).  
Plasma melatonin levels were assessed utilizing 
a commercial melatonin ELISA kit (MP Biomedicals’ 
Inc., Irvin CA). Data was collected and analyzed using 
manufacturer’s instructions and standards. Briefly, 50 
μl of samples, controls, and standards were micropi-
petted in their designated ELISA plate wells, followed 
by adding 50 μl of melatonin-biotin, then 50 μl mela-
tonin antiserum mixes, before incubating overnight at 
4 ºC. Next day, 3 washes with buffer were followed by 
incubation with 150 μl conjugate for 2 hours at room 
temperature, then washing 3 times with buffer, before 
incubation with 200 μl PNPP substance for 20-40 mi-
nutes at room temperature, then adding stop solution. 
ELISA analyzer absorbance readings were taken at 
405 nm and sample melatonin concentrations were 
calculated using their average optical densities based 
on kit standard curves.  
RT-PCR  
To determine whether the gut naturally ex-
presses the key enzymes for melatonin synthesis 
during the light hours of the day, AA-NAT and 
HIOMT mRNA expression was tested in RNA iso-Int. J. Biol. Sci. 2010, 6 
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lated from ileum and jejunum tissue specimens that 
were freshly dissected from all rat groups at ZT 8 and 
stored in RNAlater (Qiagen, Valencia, CA). To test the 
effect of exogenous melatonin on gut melatonin ex-
pression, AA-NAT mRNA was compared four hours 
after ~1 ml i.p. injection of 1.86 mg (8 μmole) or 7.43 
mg (32 μmole) /kg b.wt. exogenous melatonin (Sig-
ma-Aldrich, St Louis) dissolved in normal saline.  
RNA isolation: RNA isolation was performed 
utilizing Qiagen’s RNeasy Fibrous Tissue kit. Briefly, 
ileum and jejunum tissue segments weighting ≤ 30 mg 
were homogenized and lysed, then treated with pro-
teinase K solution in order to remove protein, con-
nective tissues, and collagen, as well as DNase to re-
move DNA. Samples were then microcentrifuged to 
remove debris before washing, eluting, then deep 
freezing high quality pure RNA until use for rtPCR.  
Reverse transcription: RNA isolated from ileum 
and jejunum tissues was processed for RT-PCR using 
the Qiagen One-Step RT-PCR kit (Qiagen, Valencia, 
CA) following manufacturer’s instructions. Briefly, 
master mix was prepared on ice by adding 10 μl 5X 
RT-PCR Buffer, 1 μl dNTP mix, 1 μl Qiagen RT-PCR 
enzyme mix, 1.50 μl forward primer, 1.50 μl reverse 
primer and 10 μl RNase-free water. Master mix (10 ul) 
was mixed in sterile tubes with template RNA (10 μl ; 
10 ng/μl ) solution and run on a PCR Sprint Thermal 
Cycler (Thermo Electron Company, Milford MA) set 
according to thermal cycler protocol as follows: Stage 
1: reverse transcriptase (cDNA) at 50 °C for 30 mi-
nutes, Stage 2: initial PCR activation at 95 °C for 15 
minutes, Stage 3: denaturation at 94 °C for 45 seconds, 
annealing at 50-68 °C for 45 seconds, then extension 72 
°C for 1 minute, and Stage 4: final extension at 72 °C 
for 10 minutes. The kit allows both reverse transcrip-
tion and PCR amplification to take place in what is 
commonly referred to as a one-step reaction. The kit 
contains OmniscriptReverse Transcriptase (ORT), 
Sensiscript Reverse Transcriptase (SRT), and HotStar 
Taq DNA polymerase (HDP) and has a reverse tran-
scription target RNA detection range of 1 pg to 2 μg.  
Primers AA-NAT (F: 5- TGA GCG CGA AGC 
CTT TAT CTC AGT; R: 3- TGT GGC ACC GTA AGG 
AAC ATT GCA) and HIOMT (F: 
5-GGTAGCTCCGTGTGTGTCTT-3’; R: 
5’-AGTGGCCAGGTTGCGGTAGT-3’) were designed 
in our lab based on Genbank and oligoprimer analysis 
software (OligoPerfect™ Designer, Invitrogen) and 
synthesized commercially by Invitrogen. House-
keeping gene, GAPDH (F: AGA TGG TGA AGG TCG 
GTG TC; R: ATT GAA CTT GCC GTG GGT AG) was 
used as a control to ensure validity, reliability, and 
proper pipette technique.  
rtPCR product visualization and densitometry. 
rtPCR amplification product (10 μl product mixture + 
2 μl dye) were loaded in triplicates in parallel with 
DNA marker (100 bp) using a 2.5 % agarose gel pre-
pared with TAE buffer. Gel was run (Gel apparatus 
model 250, GIBCO BRL Life Technologies Inc, Gai-
thersburg, MD) for 45 to 60 minutes with voltage set 
at 105 V then developed in ethidium bromide solution 
for 15 minutes before imaging with a Fluor-S MultiI-
mager (Bio-Rad). The PCR bands were digitally cap-
tured then AA-NAT/GADPH and HIOMT/GADPH 
mRNA transcript density ratios were quantified uti-
lizing Metamorph (Universal Imaging) densitometry 
software.  
Inflammation assessment with H&E and Gr-1 
and nitrotyrosine immunohistochemistry [1-3, 
35-37]:  
All staining was performed on 30 μm thick ileum 
and jejunum cross sections cut by cryostat and 
thaw-mounted on superfrost-plus slides. H&E stain-
ing colors basophilic structures with blue-purple hue 
with hematoxylin and eosinophilic structures bright 
pink with eosin Y, thus making it fairly easy to spot 
sites of inflammation marked by leukocyte infiltration 
with a light microscope. Inflammation was also con-
firmed by granulocyte-1 (Gr-1) as well as nitrotyro-
sine immunohistochemistry (IHC) examined by fluo-
rescent microscopy, whereby site-specific immuno-
labeling corresponds to neutrophil infiltration (Gr-1 
IHC) or protein nitrosylation (nitrotyrosine IHC).  
For immunohistochemistry, sections from all 
experimental groups were treated as follows: thawed 
(10 min, room temp), surrounded with a repellent 
circle using a Pap Pen, fixed with 4% formaldehyde 
( 1 0  m i n ,  r o o m  t e m p ) ,  w a s h e d  w i t h  P B S ,  i n c u b a t e d  
with 0.1% diluted goat serum in serum in PBS (30 min, 
room temp) to block nonspecific binding, incubated 
inside a humid chamber with rabbit anti-Gr-1 or 
mouse anti-nitrotyrosine primary antibody (1:1000 in 
PBS, 4 ºC, overnight), washed with PBS, incubated 
with FITC goat anti-rabbit IgG secondary antibody 
(for Gr-1) and goat-anti mouse IgG (for nitrotyrosin; 
Upstate Biotechnology, Lake Placid, NY; 1:1000 in 
P B S ,  4 5  m i n ,  r o o m  t e m p ) ,  w a s h e d  w i t h  P B S ,  c o v -
er-slipped using Crystal Mount, then dried and ana-
lyzed. 
Immunolabeling density was assessed using 
computerized digital imaging with Metamorph soft-
ware (Universal Imaging) and fluorescent microscopy 
with a TE2000-S Inverted Fluorescence Microscope 
with CFI Plan Fluor objectives. Densitometric mea-
surements for granulocyte-1 (Gr-1) as well as nitro-
tyrosine immunolabeling intensity reflect the overall 
degree of tissue inflammation. Cell counts were also Int. J. Biol. Sci. 2010, 6 
 
http://www.biolsci.org 
286
performed for Gr-1 immunopositive cells to assess 
level of gut mucosa infiltration by Gr-1 labeled cells 
from extracellular and background labeling.  
Statistical analysis:  
Quantitative ELISA, rtPCR, and microscopic cell 
count as well as densitometry measurements were 
tabulated and plotted as mean ± SE in MS Excel and 
analyzed using the Sigma Statistical program (SPSS, 
version 2.0; SigmaStat). T-tests and ANOVA as well as 
Tukey’s post-HOC analyses were used to compare 
groups and P values less than 0.05 were considered 
statistically significant.  
3. Results: 
Melatonin concentration in mesenteric versus 
general circulation and the effects of ma-
jor thermal injury:  
Our ELISA melatonin measurements re-
vealed that plasma melatonin levels in the 
mesenteric blood draining the intestines 
(221.9±9.3 pg/ml) were over 9 times those 
found in the general circulation (24.2±1.4 pg/ml) (p 
<0.01) (Fig. 1). Major thermal injury was associated 
with an almost two-fold increase in mesenteric (from 
221.9±9.3 to 393.2±22.6 pg/ml) and over than 13-fold 
increase in general circulation (from 24.2±1.4 to 
333.1±22.9 pg/ml) plasma melatonin (p<0.001) (Fig. 
1). Exogenous melatonin administration in sham rats 
(single i.p. injection; 1.86 mg/kg b.wt.) resulted in an 
increase in mesenteric as well as systemic melatonin 
to 419.9±21.4 pg/ml and 321.5±9.8 pg/ml, respec-
tively. Interestingly, this is a very close match to cir-
culating and mesenteric plasma melatonin levels seen 
in TI rats (Fig. 1A). These levels returned to normal 
levels in non-treated sham rats within 7 hours (me-
senteric plasma, 243.7±38.4 pg/ml, systemic circula-
tion, 33.9±1.1 pg/ml; data not graphed). 
 
 
Figure 1. The gut is a source of melatonin and 
levels of mesenteric melatonin and gut melatonin 
synthesizing enzymes are influenced by major 
themal injury as well as exogenous melatonin. A. In 
sham rats, ELISA melatonin measurements revealed 
that melatonin levels in mesenteric blood were 
around 9 times higher than those found in the 
general circulation (Far left bars). Contrariwise, 
plasma melatonin levels were profoundly increased 
in both mesenteric and general circulation in rats 
with a 3rd degree burn over 30% TBSA 3 days after 
thermal injury (TI, far right, p<0.01). Interestingly, 
these mesenteric and general circulation plasma 
melatonin levels were a very close match to circu-
lating and mesenteric plasma melatonin levels found 
in sham rats 2 hours after exogenous melatonin 
(Sham+mel; 2mM, 1 ml/250 g b.wt., i.p.) injection. B. 
Gut AANAT and HIOMT mRNA expression levels 
were higher (^^) in thermally injured (TI) than sham 
control (*) ileum.C. AANAT mRNA expression in 
TI subjects was more suppressed by a higher (8 
mM) than a lower (2 mM) dose of exogenous me-
latonin administered by IP injection. rtPCR prod-
ucts appear at 109 bp (AANAT), 260bp (HIOMT) 
and 222 bp (housekeeping GAPDH). All mea-
surements were performed on blood samples  and 
tissues obtained at ~ZT 8 of a 12:12 light cycle at 
resting conditions with free access to chow feed. 
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AA-NAT and HIOMT expression and the effect 
of thermal injury and exogenous melatonin ad-
ministration: 
Our rtPCR data demonstrated that AA-NAT and 
HIOMT mRNAs are expressed in ileum (Fig. 1B&C) 
and duodenum (data not shown) tissues. The expres-
sion of these two enzymes supports the possibility of 
de novo melatonin synthesis in the gut that would 
contribute to the higher melatonin levels in mesen-
teric relative to systemic blood melatonin during the 
light-day hours (Z.T. 8) when pineal melatonin pro-
duction is suppressed.  
Our data also revealed that major thermal injury 
results in robust increases in AA-NAT and HIOMT 
mRNA levels in the terminal ileum (Fig. 1B&C) 3 days 
after major thermal injury, thus supporting a possible 
contribution of increased de novo melatonin synthesis 
in the gut. In parallel with qualitative and compute-
rized densitometry analysis of rtPCR bands, our 
QrtPCR experiments confirmed that AA-NAT and 
HIOMT rtPCR products emerged in 29 to 32 cycles, 
whereas the housekeeping gene GAPDH rtPCR 
product appeared around cycle 26, the 
AA-NAT/GADPH mRNA transcript ratio increased 
by about 9% (0.99±0.007, N=3 to 1.08±0.04, N=5) and 
HIOMT/GADPH ratios increased by about 9.5% 
(0.81±0.011, N=3 to 0.89±0.03, N=5). We also observed 
that AA-NAT mRNA decreases with exogenous me-
latonin administration (Fig.1B), thus raising the pos-
sibility that gut melatonin may be subject to negative 
feedback.  
To further assess whether melatonin exerts 
feedback on its own production, we compared the 
effects of boosting melatonin levels by administering 
exogenous melatonin by i.p. injection of 1ml/250g 
b.wt. doses at 2 or 8 mM concentrations two hours 
before measuring the ileum expression levels of the 
melatonin synthesizing enzyme mRNA. Our data 
revealed that the 8 mM (1ml/250g b.wt., i.p.) dose 
diminished AA-NAT mRNA expression to about 
~5-15% of its postburn expression whereas the 2 mM 
(1ml/250g b.wt., i.p.)  dose decreased it only to 
70-80% its postburn expression (Fig. 1C).  
Melatonin decreases intestinal tissue inflamma-
tion:  
  To test whether the postburn increase in mela-
tonin (Fig. 1) contributes to postburn intestinal injury 
or represents an insufficient attempt at truncating it, 
we examined the effect of reinforcing endogenous 
melatonin production by an exogenous injection. 
T o w a r d s  t h i s  e n d ,  a  d o s e  o f  1 . 8 6  m g / k g ,  i . p .  w a s  
chosen because it increases both mesenteric and sys-
temic blood melatonin levels (Fig. 1a) without drasti-
cally decreasing levels o f  g u t  A A - N A T  m R N A  e x -
pression (Fig. 1c). The effects of such an injection are 
presented in Figs. 2-4.  
Microscopic analysis of H&E stained terminal 
ileum and duodenum tissues revealed robust signs of 
inflammation, especially in the form of mucosa neu-
trophil influx and extravasation (Fig. 2, top row, TI 
inset) on day 3 of major thermal injury. Such signs of 
inflammation were profoundly decreased in speci-
mens from melatonin-treated thermal injury rats, far 
lower in sham, and virtually absent in sham plus me-
latonin. A similar inflammation pattern was con-
firmed using Gr-1 immunohistochemistry with robust 
neutrophil influx and extravasation in the terminal 
ileum and jejunum mucosa (Fig. 2, middle row, TI 
inset). Here, we quantified and statistically analyzed 
the degree of inflammation and found approximately 
40% drop in Gr-1 immunopositive cell counts and 
over 20% decrease in Gr-1 labeling intensity (Fig. 3) 
both of which were statistically significant (p<0.01, 
N=3 to 7). The decrease in Gr-1-positive cell count, 
which showed a larger effect for melatonin, is indeed 
a better indicator of the robust anti-inflammatory ac-
tions of melatonin than overall labeling intensity, as 
the former reflects the actual change in the total 
number of infiltrating Gr-1 immunopositive cells 
(presumably neutrophils) while the latter averages 
overall color intensity of cellular, non-cellular, and 
background labeling. 
Melatonin-mediated decreases in gut mucosa 
neutrophil infiltration and inflammation were also 
further supported by a parallel decrease in one of 
their down stream manifestations, namely, tissue 
protein nitrosylation as determined by nitrotyrosine 
immunohistochemistry. This was clear in Fig. 2 (bot-
tom row) where nitrotyrosine immunoreactivity was 
very high in TI tissue but not in TI+melatonin. This 
effect is depicted quantitatively in Fig. 4, where rela-
tive density of nitrotyrosine labeling is in the order TI 
> TI+mel > sham > sham+mel, with melatonin sup-
pressing about 15% of tissue nitrosylation in melato-
nin-treated relative to TI rats (p<0.05).  
 Int. J. Biol. Sci. 2010, 6 
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Figure 2. Melatonin decreases intestinal tissue inflammation as visualized by hematoxylin and eosin (H&E) staining as well as 
Gr-1 and nitrotyrosine immunohistrochemistry (IHC). Inflammation was highest in ileum tissue of thermally injured rats (TI, 
column 3) as evidenced by tissue infiltration with extravasated neutrophils (H&E, top row; and Gr-1 IHC, middle row; see 
insets) as well nitrotyrosine immunohidtrovhemistry (bottom row). These markers were markedly decreased in melatonin 
treated rats, be they sham with melatonin (sham+Mel; second column) or thermally inured (TI+Mel; 4
th column). All 
measurements were performed on samples obtained ~ZT 8 of a 12:12 light cycle at resting conditions with free access to 
chow feed. Int. J. Biol. Sci.
Figure 3. Lev
immunofluore
injured (TI) su
burn (p<0.05)
intensity was l
~ZT 8 of a 12
Figure 4. Lev
tyrosine immu
(p<0.01). The
melatonin inje
treated sham 
conditions wit
. 2010, 6 
vels of postbur
escence intensi
ubjects relative
) subjects treat
east evident am
2:12 light cycle 
vels of postbur
unohistochemi
 signal was sig
ections (Sham+
 subjects. All m
th free access t
rn inflammation
ity (open circl
e to sham contr
ted with daily 
mong melatoni
 at resting con
rn nitrosylation
istry appeared
nificantly decr
+Mel and TI+M
measurements
to chow feed. 
n in the termin
es) and Gr-1 i
rols (p<0.01). T
 IP melatonin 
n treated sham
ditions with fre
n in the termin
 significantly h
eased in both 
Mel). Notably, 
 were perform
 
nal ileum. Tissu
immunopositiv
The signal was
injections (Sha
m subjects. All m
ee access to ch
 
nal ileum. Tissu
higher in therm
control (p<0.0
variability in la
med on sample
ue inflammatio
ve cell counting
 significantly de
am+Mel and T
measurements
how feed. 
ue nitrosylatio
mally injured (T
01) and burn (
abeling intensit
es obtained ~Z
 
n as assessed u
g was significa
ecreased in bo
TI+Mel). Notab
s were perform
 
n as assessed u
TI) subjects re
(p<0.05) subjec
ty was least ev
ZT 8 of a 12:
http://www.
using both rela
antly higher in 
oth control (p<
bly, variability i
med on samples
using quantitat
elative to sham
cts treated wit
vident among m
12 light cycle 
 
biolsci.org 
289
ative Gr-1 
thermally 
<0.01) and 
n labeling 
s obtained 
tive nitro-
m controls 
th daily IP 
melatonin 
at resting Int. J. Biol. Sci. 2010, 6 
 
 
http://www.biolsci.org 
290
4. Discussion: 
Our data shows that the gut acts a source for 
melatonin as mesenteric melatonin levels appear 
much higher than in the systemic circulation (Fig. 1A) 
and AA-NAT and HIOMT mRNAs are expressed in 
the ileum (Fig. 1B and 1C). Gut melatonin is dynami-
cally adjusted as both mesenteric and systemic mela-
tonin levels are increased three days following major 
thermal injury (Fig. 1A), AA-NAT and HIOMT 
mRNA expression is increased three days following 
major thermal injury (Fig. 1B and 1C), and exogenous 
melatonin suppresses melatonin synthesizing enzyme 
mRNA expression (Fig. 1C). Our data also demon-
strates that gut barrier tissue is a target for melatonin 
anti-inflammatory/antioxidant effects as exogenous 
melatonin supplementation suppresses postburn 
neutrophil infiltration as well as tyrosine nitrosylation 
(Figs. 2-4). Importantly, these observations were 
demonstrated in Harlan Sprague Dawley rats (and 
reproduced in BALB/c mice; data not shown) during 
the light time of the day when pineal melatonin pro-
duction is known to be suppressed.  
The gut as a source for melatonin:  
The presence of nine times as much melatonin in 
mesenteric as in general blood circulation during the 
light day hours is in accordance with previous reports 
of high gut tissue as well as bile melatonin levels 
[11-19, 22,23]. To our knowledge, this is the first time 
rat mesenteric melatonin levels have been reported in 
sham and thermally injured rats although physiolog-
ical gut tissue melatonin levels have been previously 
published [15-18]. AA-NAT and HIOMT mRNA ex-
pression in the ileum and jejunum also supports pre-
vious reports of extrapineal de novo melatonin syn-
thesis in the gut [15-18]. Indeed, high levels of me-
senteric blood melatonin could be attributed to inputs 
from  de novo gut melatonin synthesis as previous 
reports have demonstrated high gut melatonin levels 
in pinealectomized animals [16]. As such, our data 
support previous proposed models of a compart-
mentalized, gut-derived melatonin pool that is main-
tained by de novo synthesis in the gut and partial re-
cycling through entero-hepatic circulation [16]. Con-
verging evidence points to melatonin production by 
gut enterochromaffin cells, where it acts in a paracrine 
fashion in gut tissue as an antioxi-
dant/anti-inflammatory agent and gets absorbed 
through mesenteric circulation, to be passed on 
through the hepatic portal circulation to the liver, 
where it gets recycled through bile or catabolized and 
excreted through the kidneys [15-19, 22, 23, 38]. Other 
melatonin sources such as T cells in the lamina pro-
pria and gut associated lymph tissues are also possi-
ble as it has been recently demonstrated that human T 
cells can produce melatonin at levels as high as five 
times that found in nocturnal systemic plasma [39]. 
Taken together, our observations support the 
existence of a circadian-independent mesenteric blood 
melatonin compartment that intersects the bile com-
partment. Metabolically, the two compartments com-
plement each other so that mesenteric blood receives 
reabsorbed excess bile melatonin and shunts it back to 
the liver and bile along with de novo gut tis-
sue-synthesized melatonin. The steady-state outcome 
of such dynamics is a relatively small but very high 
concentration (20 to 30 fold systemic blood) bile 
compartment [23] balanced by the relatively large but 
lower concentration (~9 times systemic blood) me-
senteric blood compartment (Fig. 1A). Ultimately, 
such metabolic dynamics account for a sustained, 
robust non-circadian extra-pineal melatonin com-
partment that is largely sheltered from systemic cir-
culation by recycling/excretion with bile [15-19, 22, 
23]. Additional factors that may account for a high 
mesenteric relative to systemic melatonin levels in-
clude protein binding, rapid 6-hydroxylation and 
conjugation in the liver and excretion as 6-hydroxy 
conjugates and 6-sulfatoxymelatonin by the kidneys 
[15-19, 22, 23]. Interestingly, our data shows that 
doubling the mesenteric melatonin levels (due to 
thermal injury or by i.p. exogenous 1.86 mg/kg me-
latonin injection) is associated with a drastic rise in 
systemic melatonin (Fig. 1A). These data suggest an 
upper saturation limit for the mechanisms responsible 
for compartmentalizing or restricting gut melatonin to 
mesenteric/entero-hepatic circulation. 
In thermally injured rats, the large increase in 
systemic melatonin is attributable to multiple factors 
that include increased melatonin synthesizing en-
zyme expression (Fig. 1B, C). As discussed below this 
endogenous melatonin increase is evidently not suffi-
cient to counteract postburn gut barrier inflammatory 
complications. Indeed, it is quite possible that nega-
tive feedback (Fig. 1C) may put a cap on how much 
melatonin synthesizing enzyme expression can be 
ratcheted up in response to major thermal injury. 
Remarkably, melatonin synthesizing enzyme mRNA 
expression appears to undergo suppression in sham 
rats following exogenous intraperitoneal melatonin 
injection possibly starting at concentrations as low as 
those seen postburn (2 mM; Fig. 1). Additionally, 
doubling of mesenteric melatonin levels, be it in asso-
ciation with major thermal injury or exogenous injec-
tion, appears to be associated with a dramatic increase 
in systemic melatonin (Fig. 1A). Whereas such spil-
lover effect could have the benefit of tapping into Int. J. Biol. Sci. 2010, 6 
 
http://www.biolsci.org 
291
mesenteric melatonin for systemic use, it has the side 
effect of limiting its availability for local use.  This is 
not to say that the increase in systemic postburn me-
latonin is entirely due to increased mesenteric mela-
tonin. Other possible factors include a postburn 
change in dynamics outside the entero-hepatic pool 
and/or a postburn change in liver melatonin han-
dling, namely, metabolism, and bile excretion [15-19, 
22, 23].  
The gut as a target for melatonin:  
Our data provides support for a strong an-
ti-inflammatory/antioxidant role for melatonin in the 
gut when administered intraperitoneally (1.86 mg/kg, 
i.p.) (Figs. 2 and 3). These data are in agreement with 
several recent reports indicating an an-
ti-inflammatory/antioxidant  role for melatonin, as 
well as data linking extra-pineal melatonin imbalance 
to various pathologies [10-14, 24-32, 40-42], including 
reports that specifically examined gut pathophysiol-
ogy [10-14] and/or complications of burn injury 
[40-42]. Our data and those of others suggest that 
melatonin actions include anti-inflammatory me-
chanisms that involve blocking neutrophil extravasa-
tion, lymphocyte melatonin production, and/or NFκB 
activation [25,27,39,42]. Our results also show that 
melatonin drastically suppresses but does not com-
pletely abrogate postburn gut inflammation which 
leaves the door open for other mechanisms such as 
those involving molecular circadian clock distur-
bances [8,9,43-45].  
Regardless of its trigger, our data suggest a 
gut-mediated, compensatory anti-inflammatory re-
sponse to major thermal injury associated with in-
creased gut melatonin expression and mesenteric 
melatonin levels (Fig. 1). Interestingly, this rise in gut 
melatonin is associated with a sharp increase in sys-
temic melatonin (Fig. 1A) which may be associated 
with lethargy and sleepiness seen in thermally injured 
rats. This could be beneficial for channeling body 
energy towards tissue repair. However, the increase 
in mesenteric melatonin falls short in terms of its 
ability to prevent gut tissue inflammation as evi-
denced by the beneficial effects of exogenous melato-
nin supplementation (Figs. 2-4). Three possible me-
chanisms through which melatonin could decrease 
inflammation are: (A) decrease leukocyte adhesion 
and extravasation and nitrotyrosine formation as re-
ported in the current work (Fig. 2,3), (B) chemical 
quenching of oxygen radical production [26,30], and 
(C) decreased NFκB activation [27]. These mechan-
isms, which might be interlinked, could play a major 
role in melatonin-mediated decreases in intestinal 
tissue neutrophil infiltration and protein nitrosylation 
and thus protection against gut barrier damage.  
In summary, the gut appears to possess the abil-
ity to produce melatonin and to pathophysiologically 
adjust mesenteric melatonin levels independent of 
circadian pineal fluctuations. Endogenous mesenteric 
as well as systemic melatonin levels are increased in 
response to major thermal injury but fall short of ab-
rogating the massive wave of postburn inflammation 
manifested in the gut by neutrophil infiltration, tissue 
oxidation and nitrosylation and gut barrier damage. 
Supplementation by exogenous melatonin signifi-
cantly suppresses gut inflammation thus confirming 
that melatonin is protective against postburn in-
flammation. These observations support our hypo-
thesis that the gut is both a source and a target for 
melatonin. Furthermore, melatonin could be a major 
dynamic player in tipping the balance of gut ho-
meostasis on the inflammation scale and henceforth 
contribute to setting the stage for individual varia-
tions in the degrees of susceptibility to gut inflamma-
tion and/or responsiveness to exogenous an-
ti-inflammatory intervention. 
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